The  ||| S:0 E:4 ||| DT
health  ||| S:4 E:11 ||| NN
care  ||| S:11 E:16 ||| NN
costs  ||| S:16 E:22 ||| NNS
of  ||| S:22 E:25 ||| IN
breast  ||| S:25 E:32 ||| JJ
cancer ||| S:32 E:38 ||| NN
:  ||| S:38 E:40 ||| :
the  ||| S:40 E:44 ||| DT
case  ||| S:44 E:49 ||| NN
of  ||| S:49 E:52 ||| IN
the  ||| S:52 E:56 ||| DT
Mexican  ||| S:56 E:64 ||| NNP
Social  ||| S:64 E:71 ||| NNP
Security  ||| S:71 E:80 ||| NNP
Institute  ||| S:80 E:90 ||| NNP
We  ||| S:90 E:93 ||| PRP
studied  ||| S:93 E:101 ||| VBD
the  ||| S:101 E:105 ||| DT
cost  ||| S:105 E:110 ||| NN
of  ||| S:110 E:113 ||| IN
health  ||| S:113 E:120 ||| NN
care  ||| S:120 E:125 ||| NN
for  ||| S:125 E:129 ||| IN
women  ||| S:129 E:135 ||| NNS
with  ||| S:135 E:140 ||| IN
breast  ||| S:140 E:147 ||| JJ
cancer  ||| S:147 E:154 ||| NN
treated  ||| S:154 E:162 ||| VBN
at  ||| S:162 E:165 ||| IN
the  ||| S:165 E:169 ||| DT
Mexican  ||| S:169 E:177 ||| NNP
Social  ||| S:177 E:184 ||| NNP
Security  ||| S:184 E:193 ||| NNP
Institute  ||| S:193 E:203 ||| NNP
( ||| S:203 E:204 ||| -LRB-
IMSS ||| S:204 E:208 ||| NNP
,  ||| S:208 E:210 ||| ,
per  ||| S:210 E:214 ||| IN
its  ||| S:214 E:218 ||| PRP$
abbreviation  ||| S:218 E:231 ||| NN
in  ||| S:231 E:234 ||| IN
Spanish ||| S:234 E:241 ||| NNP
) ||| S:241 E:242 ||| -RRB-
.  ||| S:242 E:244 ||| .
Using  ||| S:244 E:250 ||| VBG
the  ||| S:250 E:254 ||| DT
Medical  ||| S:254 E:262 ||| NNP
and  ||| S:262 E:266 ||| CC
Operative  ||| S:266 E:276 ||| NNP
Information  ||| S:276 E:288 ||| NNP
Systems  ||| S:288 E:296 ||| NNPS
of  ||| S:296 E:299 ||| IN
the  ||| S:299 E:303 ||| DT
IMSS ||| S:303 E:307 ||| NNP
,  ||| S:307 E:309 ||| ,
we  ||| S:309 E:312 ||| PRP
constructed  ||| S:312 E:324 ||| VBD
a  ||| S:324 E:326 ||| DT
cohort  ||| S:326 E:333 ||| NN
of  ||| S:333 E:336 ||| IN
patients  ||| S:336 E:345 ||| NNS
diagnosed  ||| S:345 E:355 ||| VBN
in  ||| S:355 E:358 ||| IN
2002  ||| S:358 E:363 ||| CD
and  ||| S:363 E:367 ||| CC
followed  ||| S:367 E:376 ||| VBD
these  ||| S:376 E:382 ||| DT
patients  ||| S:382 E:391 ||| NNS
to  ||| S:391 E:394 ||| TO
the  ||| S:394 E:398 ||| DT
end  ||| S:398 E:402 ||| NN
of  ||| S:402 E:405 ||| IN
2006 ||| S:405 E:409 ||| CD
,  ||| S:409 E:411 ||| ,
identifying  ||| S:411 E:423 ||| VBG
the  ||| S:423 E:427 ||| DT
use  ||| S:427 E:431 ||| NN
of  ||| S:431 E:434 ||| IN
resources  ||| S:434 E:444 ||| NNS
and  ||| S:444 E:448 ||| CC
imputing  ||| S:448 E:457 ||| VBG
the  ||| S:457 E:461 ||| DT
IMSS-specific  ||| S:461 E:475 ||| JJ
cost  ||| S:475 E:480 ||| NN
structure ||| S:480 E:489 ||| NN
.  ||| S:489 E:491 ||| .
Only  ||| S:491 E:496 ||| RB
14 ||| S:496 E:498 ||| CD
%  ||| S:498 E:500 ||| NN
of  ||| S:500 E:503 ||| IN
women  ||| S:503 E:509 ||| NNS
were  ||| S:509 E:514 ||| VBD
diagnosed  ||| S:514 E:524 ||| VBN
in  ||| S:524 E:527 ||| IN
stage  ||| S:527 E:533 ||| NN
1  ||| S:533 E:535 ||| CD
and  ||| S:535 E:539 ||| CC
48 ||| S:539 E:541 ||| CD
%  ||| S:541 E:543 ||| NN
were  ||| S:543 E:548 ||| VBD
diagnosed  ||| S:548 E:558 ||| VBN
in  ||| S:558 E:561 ||| IN
stages  ||| S:561 E:568 ||| NNS
III-IV ||| S:568 E:574 ||| JJ
.  ||| S:574 E:576 ||| .
The  ||| S:576 E:580 ||| DT
average  ||| S:580 E:588 ||| JJ
cost  ||| S:588 E:593 ||| NN
of  ||| S:593 E:596 ||| IN
their  ||| S:596 E:602 ||| PRP$
medical  ||| S:602 E:610 ||| JJ
care  ||| S:610 E:615 ||| NN
per  ||| S:615 E:619 ||| IN
patient-year  ||| S:619 E:632 ||| NNP
was  ||| S:632 E:636 ||| VBD
$ ||| S:636 E:637 ||| $
MX110,459 ||| S:637 E:646 ||| CD
.  ||| S:646 E:648 ||| .
Costs  ||| S:648 E:654 ||| NNS
for  ||| S:654 E:658 ||| IN
stage  ||| S:658 E:664 ||| NN
1  ||| S:664 E:666 ||| CD
were  ||| S:666 E:671 ||| VBD
$ ||| S:671 E:672 ||| $
MX74,522  ||| S:672 E:681 ||| CD
compared  ||| S:681 E:690 ||| VBN
to  ||| S:690 E:693 ||| TO
$ ||| S:693 E:694 ||| $
102,042  ||| S:694 E:702 ||| CD
for  ||| S:702 E:706 ||| IN
stage  ||| S:706 E:712 ||| NN
II ||| S:712 E:714 ||| NNP
,  ||| S:714 E:716 ||| ,
and  ||| S:716 E:720 ||| CC
were  ||| S:720 E:725 ||| VBD
$ ||| S:725 E:726 ||| $
MX154,018  ||| S:726 E:736 ||| CD
for  ||| S:736 E:740 ||| IN
stage  ||| S:740 E:746 ||| NN
III  ||| S:746 E:750 ||| NNP
and  ||| S:750 E:754 ||| CC
$ ||| S:754 E:755 ||| $
MX199,274  ||| S:755 E:765 ||| CD
for  ||| S:765 E:769 ||| IN
stage  ||| S:769 E:775 ||| NN
IV ||| S:775 E:777 ||| NNP
.  ||| S:777 E:779 ||| .
Breast  ||| S:779 E:786 ||| JJ
cancer  ||| S:786 E:793 ||| NN
accounts  ||| S:793 E:802 ||| NNS
for  ||| S:802 E:806 ||| IN
a  ||| S:806 E:808 ||| DT
significant  ||| S:808 E:820 ||| JJ
part  ||| S:820 E:825 ||| NN
of  ||| S:825 E:828 ||| IN
the  ||| S:828 E:832 ||| DT
IMSS  ||| S:832 E:837 ||| NNP
health  ||| S:837 E:844 ||| NN
budget ||| S:844 E:850 ||| NN
.  ||| S:850 E:852 ||| .
Later  ||| S:852 E:858 ||| RB
stage  ||| S:858 E:864 ||| VB
at  ||| S:864 E:867 ||| IN
diagnosis  ||| S:867 E:877 ||| NN
is  ||| S:877 E:880 ||| VBZ
associated  ||| S:880 E:891 ||| VBN
with  ||| S:891 E:896 ||| IN
higher  ||| S:896 E:903 ||| JJR
economic  ||| S:903 E:912 ||| JJ
costs  ||| S:912 E:918 ||| NNS
per  ||| S:918 E:922 ||| IN
patient-year  ||| S:922 E:935 ||| JJ
of  ||| S:935 E:938 ||| IN
treatment  ||| S:938 E:948 ||| NN
and  ||| S:948 E:952 ||| CC
lower  ||| S:952 E:958 ||| JJR
probability  ||| S:958 E:970 ||| NN
of  ||| S:970 E:973 ||| IN
five-year  ||| S:973 E:983 ||| JJ
survival ||| S:983 E:991 ||| NN
.  ||| S:991 E:993 ||| .
